Evidence map›Paper›PMID 42293476›Full record

ArticleRadiology case reports2026

Right-lobe hepatic mucinous cystic neoplasm with an adjacent large hemorrhagic-appearing cyst: Markedly elevated serum CEA and CA19-9 despite benign imaging/pathology.

Taku Miyanaga, Gaku Honda, Kazuhide Takata, Shigetoshi Naito, Yoshihiro Hamada, Kengo Yoshimitsu

Abstract readCase Reports
In one paragraph

Article in Radiology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Taku MiyanagaDepartment of Radiology, Fukuoka University, Faculty of Medicine, Fukuoka, Japan.
Gaku HondaDepartment of Radiology, Fukuoka University, Faculty of Medicine, Fukuoka, Japan.
Kazuhide TakataDepartment of Gastroenterology and Medicine, Fukuoka University, Faculty of Medicine, Fukuoka, Japan.
Shigetoshi NaitoDepartment of Gastrointestinal surgery, Fukuoka University, Faculty of Medicine, Fukuoka, Japan.
Yoshihiro HamadaDepartment of Diagnostic Pathology, Fukuoka University, Faculty of Medicine, Fukuoka, Japan.
Kengo YoshimitsuDepartment of Radiology, Fukuoka University, Faculty of Medicine, Fukuoka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mucinous cystic neoplasm (MCN) is a multilocular cystic mass that most commonly develops in the pancreas, whereas its occurrence in the liver is relatively rare and typically involves the left lobe. We report a case of right-lobe hepatic MCN in a woman in her 60s, accompanied by markedly elevated serum CEA and CA19-9 levels and an adjacent large hemorrhagic-appearing cyst. Contrast-enhanced CT demonstrated a 10-cm multilocular cystic tumor with a cyst-in-cyst configuration, gradual septal enhancement, partial septal calcification, and no enhancing mural nodules. MRI demonstrated a stained glass-like appearance with no diffusion restriction. She underwent right hepatic lobectomy with diaphragmatic resection, and pathological examination confirmed MCN with ovarian-like stroma without malignant transformation. The postoperative course was uneventful. Serum levels of CEA and CA19-9 normalized one month postoperatively, and no recurrence has been observed during follow-up. When a multilocular cystic mass with cyst-in-cyst morphology and a stained glass-like appearance is identified in the liver-even in the absence of definite malignant imaging features-MCN should be considered, including in cases arising in the right hepatic lobe.

Indexed as

Mucinous cystic neoplasmPET CTR2*mapRight hepatic lobe

Identifiers

PMID42293476
PMCPMC13254940

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.